PropertyValue
?:abstract
  • OBJECTIVE In this study we describe the management of women with gestational diabetes (GD) and an ongoing Sars-Cov-2 infection. The aim of the study is to evaluate whether the COVID-19 infection can further complicate pregnancies and thus if the protocol we usually use for GDM pregnancies is also applicable to patients who have contracted a Sars-Cov-2 infection. METHODS This is a retrospective study analysing all pregnant women with gestational diabetes and a concomitant COVID-19 infection admitted to our Institution for antenatal care between March 1st and April 30th 2020. RESULTS Among pregnant women with GD and a concomitant COVID-19 infection, the mean age was 32,9 (SD 5,6) years. Two patients (33%) were of Caucasian ethnicity while four (67%) were non-Caucasian. All patients were diagnosed with COVID-19 during the third trimester of pregnancy. Two women were asymptomatic while four were symptomatic. Only two patients (33,3%) received treatment with insulin. None of the patients required intensive care or mechanical ventilation. No complications were found among the newborns. CONCLUSION the COVID-19 infection was not found to worsen the prognosis of GD patients or of their offspring. Glycaemic monitoring, diet therapy and insulin, when needed, are sufficient for a good metabolic control and a favourable maternal and fetal outcome.
?:creator
?:doi
  • 10.1002/ijgo.13434
?:doi
?:journal
  • International_journal_of_gynaecology_and_obstetrics:_the_official_organ_of_the_International_Federation_of_Gynaecology_and_Obstetrics
?:license
  • unk
?:pmid
?:pmid
  • 33099770
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • Management of gestational diabetes in women with a concurrent Sars-Cov-2 infection, experience of a single center in Northern Italy.
?:type
?:year
  • 2020-10-25

Metadata

Anon_0  
expand all